Buprenorphine Sublingual C-iii Tablet
Product Images NDC 72189-580

2 FDA label images from Direct_rx · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Buprenorphine Sublingual C-iii (NDC 72189-580). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct_rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72189-580-90 (72189 580 90)

72189-580-90 (72189 580 90)
Label for Buprenorphine Sublingual C-III 2 mg tablets, containing 90 tablets per package. The label notes this product is generic for Subutex and each tablet contains 2.16 mg buprenorphine HCL, equivalent to 2 mg buprenorphine base. It is packaged and distributed by Direct Rx.*
FDA Label Image

72189-580-60 (72189 580 60)

72189-580-60 (72189 580 60)
Buprenorphine Sublingual C-III 2 mg sublingual tablets, packaged in a bottle label indicating 60 tablets per bottle. The label states it is a generic equivalent for Subutex and provides the active ingredient amount as 2.16 mg of buprenorphine HCL USP, equivalent to 2 mg buprenorphine base. The product is packaged and distributed by Direct Rx, with lot number 160C2405 and an expiration date of 10/31/25.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.